EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Recombinant Vitronectin Variant Supports the Expansion and Differentiation of Pluripotent Stem Cells in Defined Animal-Free Workflows

Xi Lu, Eli Perr, Tahmina Naqvi, David Galitz, Marnelle Andersen, David Grabowski, Anthony Person, Alex Kalyuzhny iD, Kevin C Flynn

Cells · 2024

DOI: 10.3390/cells13181566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Xi Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell & Gene Therapy, Bio-Techne, Minneapolis, MN 55413, USA. Hauptthemen laut MEDLINE: Vitronectin, Cell Differentiation, Induced Pluripotent Stem Cells, Recombinant Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An essential aspect of harnessing the potential of pluripotent stem cells (PSCs) and their derivatives for regenerative medicine is the development of animal-free and chemically defined conditions for ex vivo cultivation. PSCs, including embryonic and induced PSCs (iPSCs), are in the early stages of clinical trials for various indications, including degenerative diseases and traumatic injury. A key step in the workflows generating these cells for more widespread clinical use is their safe and robust ex vivo cultivation. This entails optimization of cell culture media and substrates that are safe and consistent while maintaining robust functionality. Here, we describe the design of a human vitronectin (hVTN) variant with improved manufacturability in a bacterial expression system along with improved function in comparison to wild-type VTN and other previously characterized polypeptide fragments. In conjunction with an animal component-free media formulation, our hVTN fragment provides animal-free conditions for the enhanced expansion of iPSCs. This hVTN variant also supports the reprogramming of PBMCs into iPSCs. Furthermore, we show that these iPSCs can be efficiently differentiated into the three major germ layers and cortical neurons, thereby closing the loop on a completely defined animal-free workflow for cell types relevant for regenerative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitronectinCell DifferentiationInduced Pluripotent Stem CellsRecombinant ProteinsHumansPluripotent Stem CellsAnimalsCell ProliferationCellular ReprogrammingWorkflowMice

Stichwörter der Autor:innen

animal-freepluripotent stem cellssubstratevitronectin

Substanzen

VitronectinRecombinant Proteins

Autor:innen und Institutionen

  • Stem Cell & Gene Therapy, Bio-Techne, Minneapolis, MN 55413, USA.
  • Protein Development, Bio-Techne, Minneapolis, MN 55413, USA.
  • Antibody Applications, Bio-Techne, Minneapolis, MN 55413, USA.
  • Department of Biochemistry & Molecular Biology, Colorado State University, Fort Collins, CO 80523, USA.

ORCID-Profile: Alex Kalyuzhny

Zitieren

APA

Lu, X., Perr, E., Naqvi, T., Galitz, D., Andersen, M., Grabowski, D., Person, A., Kalyuzhny, A., & Flynn, K. C. (2024). A Novel Recombinant Vitronectin Variant Supports the Expansion and Differentiation of Pluripotent Stem Cells in Defined Animal-Free Workflows. Cells. https://doi.org/10.3390/cells13181566

Vancouver

Lu X, Perr E, Naqvi T, Galitz D, Andersen M, Grabowski D, et al. A Novel Recombinant Vitronectin Variant Supports the Expansion and Differentiation of Pluripotent Stem Cells in Defined Animal-Free Workflows. Cells. 2024. doi:10.3390/cells13181566

BibTeX
@article{Lu2024,
  author = {Lu, Xi and Perr, Eli and Naqvi, Tahmina and Galitz, David and Andersen, Marnelle and Grabowski, David and Person, Anthony and Kalyuzhny, Alex and Flynn, Kevin C},
  title = {A Novel Recombinant Vitronectin Variant Supports the Expansion and Differentiation of Pluripotent Stem Cells in Defined Animal-Free Workflows},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13181566}
}
Kostenlos starten →